Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1033 record(s)

Req # A-2022-001235

Total amount of money given to Canadian Virtual Hospice by Health Canada to pay for the development and creation of the activity book at this link: https://www.virtualhospice.ca/maid/media/3bdlkrve/maid-activity-book.pdf.

Organization: Health Canada

2 page(s)
January 2023

Req # A-2022-001026

Adverse Drug Reaction (ADR). Report number: E2B_03070528.

Organization: Health Canada

280 page(s)
January 2023

Req # A-2022-001041

Adverse Drug Reactions (ADRs). Report numbers: E2B_05653106, E2B_05632251, E2B_05635022, E2B_05653113, E2B_05643492.

Organization: Health Canada

68 page(s)
January 2023

Req # A-2022-001084

Adverse Drug Reactions (ADRs) for ARIPIPRAZOLE. Report numbers: E2B_05628287, E2B_05628312, E2B_05628332, E2B_05646859, E2B_05657705, E2B_05664355, E2B_05665043, E2B_05665088, E2B_05704273, E2B_05712679.

Organization: Health Canada

436 page(s)
January 2023

Req # A-2022-001087

Adverse Drug Reactions (ADRs) for ABILIFY MAINTENA. Report numbers: E2B_05665045, E2B_05665144, E2B_05686891, E2B_05693250, E2B_05695992, E2B_05703028, E2B_05711493.

Organization: Health Canada

165 page(s)
January 2023

Req # A-2021-02440

Obtain a complete copy of the note DM – 284970: Letters to Incoming and Outgoing Deputy Ministers of the Newfoundland and Labrador Department of Environment and Climate Change.

Organization: Environment and Climate Change Canada

9 page(s)
December 2022

Req # A-2022-00446

Copy of briefing note MIN – 286742: Environmental Protection Branch.

Organization: Environment and Climate Change Canada

10 page(s)
December 2022

Req # A-2022-01100

Complete copy of analyses to measure the performance of your employees working remotely since the start of the pandemic from March 1, 2020, to September 5, 2022.

Organization: Environment and Climate Change Canada

15 page(s)
December 2022

Req # A-2022-01477

Scientific records that support the existence of a climate “emergency/crisis.”

Organization: Environment and Climate Change Canada

1 page(s)
December 2022

Req # A-2022-000047

Adverse Drug Reaction (ADR) for GLYCERYL TRINITRATE. Report number: E2B_05006504. ADRs for CLOPIDOGREL BISULFATE. Report numbers: E2B_04798666, E2B_04188590.

Organization: Health Canada

64 page(s)
December 2022
Date modified: